Doç. Dr. NADİR YALÇIN

Yayın Ağı

Makaleler 65

1. Optimizing critical care pharmacotherapy: dynamic prospective evaluation of the medication regimen complexity-intensive care unit (MRC-ICU) score in critically ill patients.

Balaban U., Yalçın N., Kaya E. K., Ortaç Ersoy N. E., Demirkan S. K.

Scientific reports , 2026 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Silent Struggles in Healthcare Education: Eating Disorder Risk and Awareness Among Future Pharmacists.

Şahin E. S., Yalçın N.

American journal of pharmaceutical education , ss.101893, 2025 (SCI-Expanded, Scopus)

3. Vitamin C and postoperative outcomes following mandibular third molar extraction: a randomized split-mouth study.

Demirel M., Aktas A., Kizil M., Yalcin N.

Oral surgery, oral medicine, oral pathology and oral radiology , 2025 (SCI-Expanded, Scopus)

4. Drug-Drug Interactions in Vanzacaftor-Tezacaftor-Deutivacaftor versus Elexacaftor- Tezacaftor-Ivacaftor.

Ar E. D. A., Yalcin N.

Pulmonary pharmacology & therapeutics , ss.102395, 2025 (SCI-Expanded, Scopus)

5. Drug safety signals in breastfeeding: Bridging evidence from European and US pharmacovigilance systems

Yalcin H., YALÇIN N., Ceulemans M., Allegaert K.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , 2025 (SCI-Expanded, Scopus)

6. Leveraging Deep Learning to Enhance Malnutrition Detection via Nutrition Risk Screening 2002: Insights from a National Cohort

YALÇIN N., KAŞIKCI ÇAVDAR M., Kelleci-Cakir B., Demirkan K., Allegaert K., Halil M., et al.

NUTRIENTS , cilt.17, sa.16, 2025 (SCI-Expanded, Scopus)

7. Bone-modifying agents and survival in patients treated with immune checkpoint inhibitors

BAŞ O., GÜNER N. İ., Tokatlı M., GÜDÜK N., ŞAHİN T. K., YALÇIN N., et al.

Journal of medicine and palliative care (Online) , cilt.6, 2025 (TRDizin)

8. Assessment of nutritional indices for predicting clinical outcomes in critically ill elderly patients: a prospective cohort study

Balaban U., Yalçın N., Kaya E. K., Ortaç Ersoy N. E., Demirkan S. K.

BMC ANESTHESIOLOGY , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Real-World Safety Profile of Proton Pump Inhibitors in Infants as Reported in the FDA Adverse Event Reporting System (FAERS): Tiny Tummies, Key Decisions.

Tezel Yalçın H., Yalçın N., Allegaert K.

Pharmaceuticals (Basel, Switzerland) , cilt.18, sa.5, 2025 (SCI-Expanded, Scopus)

10. Machine learning models for predicting malnutrition in NICU patients: A comprehensive benchmarking study.

Janssen S. M. W., Bouzembrak Y., Yalcin N., Tekinerdogan B.

Computers in biology and medicine , cilt.192, sa.Pt B, ss.110326, 2025 (SCI-Expanded, Scopus)

11. Are adult cystic fibrosis patients satisfied with medication treatment?

AKMAN AR E. D., YALÇIN N., KARCIOĞLU O., DAMADOĞLU E., KALYONCU A. F., Demirkan K.

ORPHANET JOURNAL OF RARE DISEASES , sa.1, 2025 (SCI-Expanded, Scopus)

12. Medication adherence and attitudes in adolescent psychiatry: Key influences

Bayraktar İ., YALÇIN N., NALBANT K., Kultur E. c., Demirkan K.

CLINICAL CHILD PSYCHOLOGY AND PSYCHIATRY , cilt.30, sa.2, ss.516-528, 2025 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

13. Dexmedetomidine in neonates: utilisation trends and safety profile over time in a neonatal intensive care unit.

Kayki G., Yalcin N., Celik H. T., Yigit S.

BMJ paediatrics open , cilt.9, sa.1, 2025 (SCI-Expanded)

14. Differences in clozapine metabolism across geographical regions in Turkiye

MUTLU E., Ozerhan S., Iman M. F., BAYRAKTAR ALKAN İ., YALÇIN N., Demirkan K., et al.

DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES , sa.1, ss.25-32, 2025 (ESCI, Scopus, TRDizin)

15. Pharmacogenetic Variant Related Higher-Than-Expected Clozapine Concentrations and Clozapine/Norclozapine Ratios in a Patient With Treatment-Resistant Schizoaffective Disorder A Case Report

Yalçın N., Bayraktar İ., Akyol A., Deger I., İman M. F., Mutlu E., et al.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , cilt.45, sa.2, ss.163-165, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. Mathematical Albumin Function for Neonates Undergoing Therapeutic Hypothermia in Comparison with Control Neonates.

Vander Elst Z., Stultjens T., Annaert P., Clarke P., Iglesias-Platas I., Agathos E., et al.

Journal of clinical pharmacology , 2025 (SCI-Expanded, Scopus)

17. Optimizing Individualized Antimicrobial Dosing in Pediatric Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Yalçın N., Dirik Y., Bayraktar İ., Umaroğlu M., Allegaert K.

CLINICAL DRUG INVESTIGATION , cilt.45, sa.1, ss.1-16, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Advancing patient care: novel scales for assessing adherence and attitudes toward medication among adolescents with psychiatric disorders and their parents

Bayraktar İ., Yalcin N., Nalbant K., Karabulut E., Kultur E. C., Demirkan K.

EUROPEAN CHILD & ADOLESCENT PSYCHIATRY , cilt.33, sa.12, ss.4393-4403, 2024 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

19. Drug Safety During Breastfeeding: A Comparative Analysis of FDA Adverse Event Reports and LactMed®

Yalcin H., YALÇIN N., Ceulemans M., Allegaert K.

PHARMACEUTICALS , cilt.17, sa.12, 2024 (SCI-Expanded, Scopus)

20. Neonatal Clinical Pharmacology.

Allegaert K., Yalcin N., Flint R. B., Simons S. H. P.

Children (Basel, Switzerland) , cilt.11, sa.9, 2024 (SCI-Expanded, Scopus)

21. Evaluation of treatment satisfaction and related factors in adult cystic fibrosis patients

AKMAN AR E. D., YALÇIN N., Aydin D., DAMADOĞLU E., KALYONCU A. F., Demirkan K.

EUROPEAN RESPIRATORY JOURNAL , 2024 (SCI-Expanded, Scopus)

22. Fentanyl in neonates, a population pharmacokinetic, -genetic and -dynamic study.

Yalçın N., Allegaert K.

Pediatric research , 2024 (SCI-Expanded, Scopus)

23. Pharmacy students' awareness of LGBT people and related pharmaceutical knowledge levels

YALÇIN N., Gunes Z.

ISTANBUL JOURNAL OF PHARMACY , sa.2, ss.247-254, 2024 (ESCI, TRDizin)

24. A Novel Machine-Learning Algorithm to Predict the Early Termination of Nutrition Support Team Follow-Up in Hospitalized Adults: A Retrospective Cohort Study.

Yalçın N., Kaşıkcı M., Kelleci-Çakır B., Allegaert K., Güner-Oytun M., Ceylan S., et al.

Nutrients , cilt.16, sa.15, 2024 (SCI-Expanded, Scopus)

25. Optimization of appropriate antimicrobial prophylaxis in general surgery: a prospective cohort study.

Doğan C. Z., Yalçın N., Cennet Ö., Metan G., Demirkan K., Yorgancı K.

European journal of medical research , cilt.29, sa.1, ss.340, 2024 (SCI-Expanded, Scopus)

26. Evaluation of General Surgery Physicians Approaches to Surgical Antimicrobial Prophylaxis by Questionnaire Method

DOĞAN C. Z., YALÇIN N., CENNET Ö., DEMİRKAN S. K., YORGANCI H. K.

Çukurova Anestezi ve Cerrahi Bilimler Dergisi , cilt.7, sa.2, ss.99-103, 2024 (TRDizin)

27. Effect of Modulator Therapies on Nutritional Risk Index in Adults with Cystic Fibrosis: A Prospective Cohort Study

Yalçın N., Akman E. D., Karcıoğlu O., Allegaert K., Demirkan K., Damadoğlu E., et al.

NUTRIENTS , cilt.16, sa.12, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

28. Psychiatrists’ and Infectious Disease Physicians’ Awareness and Knowledge Level of Drug-Drug Interactions Between Antiretrovirals and Psychotropics: A Comparative Questionnaire-Based Study

YALÇIN N., İNKAYA A. Ç., KARA E., BAŞAR K., KARADAĞ Ö., DEMİRKAN S. K., et al.

FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.49, sa.2, ss.333-344, 2024 (Scopus, TRDizin)

29. Adherence to medical treatment for Wilson's disease in children and adolescents: a cohort study from Turkey.

Göktaş M. A., Yalcin N.

Orphanet journal of rare diseases , cilt.19, sa.1, ss.105, 2024 (SCI-Expanded, Scopus)

30. Concomitant drug use of nirmatrelvir/ritonavir and CYP3A4-modulating antimicrobial agents: an approach for drug use

Visscher R., Yalçın N., Bayraktar İ., Bayraktar-Ekincioglu A.

EUROPEAN JOURNAL OF HOSPITAL PHARMACY , cilt.31, sa.2, ss.180-182, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Web Survey of Turkish Pharmacy Students Comparing First and Fifth Years' Antidepressant Awareness and Stigmatizing Attitudes Regarding Depression and Anxiety.

Yalçın N., Özkan G. G., Allegaert K., Ak S., Demirkan K.

Pharmacy (Basel, Switzerland) , cilt.12, sa.2, 2024 (ESCI)

32. Medication and Dose Optimization in Extracorporeal Membrane Oxygenation

YALÇIN N., DEMİRKAN S. K., Akkaya M., YALÇIN N.

TURKISH JOURNAL OF INTENSIVE CARE-TURK YOGUN BAKIM DERGISI , sa.1, ss.1-14, 2024 (ESCI, TRDizin) Sürdürülebilir Kalkınma

33. Drug related adverse event assessment in neonates in clinical trials and clinical care.

Yalcin N., van den Anker J., Samiee-Zafarghandy S., Allegaert K.

Expert review of clinical pharmacology , cilt.17, ss.803-816, 2024 (SCI-Expanded, Scopus)

34. Clinical pharmacist-led assessment and management of anticholinergic burden and fall risk in geriatric patients.

Saz H. G., Yalçın N., Demirkan K., Halil M. G.

BMC geriatrics , cilt.23, sa.1, ss.863, 2023 (SCI-Expanded, SSCI, Scopus)

35. Development and validation of machine learning-based clinical decision support tool for identifying malnutrition in NICU patients

Yalçın N., Kaşıkcı M., Çelik H. T., Demirkan K., Yiğit Ş., Yurdakök M.

Scientific Reports , cilt.13, sa.1, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

36. Education and clinical pharmacist-led management strategies for the risk and prophylaxis of venous thromboembolism in general surgery.

Kiracı Z. K., Yalçın N., Cennet Ö., Demirkan K., Yorgancı K.

Thrombosis journal , cilt.21, sa.1, ss.86, 2023 (SCI-Expanded, Scopus)

37. Pharmacogenetic testing in psychiatry: Perspective on clinical utility.

Adiukwu F., Adesokun O., Essien E., Yalcin N., Ransing R., Nagendrappa S., et al.

Asian journal of psychiatry , cilt.86, ss.103674, 2023 (SCI-Expanded, Scopus)

38. Development and validation of a machine learning-based detection system to improve precision screening for medication errors in the neonatal intensive care unit.

Yalçın N., Kaşıkcı M., Çelik H. T., Allegaert K., Demirkan K., Yiğit Ş., et al.

Frontiers in pharmacology , cilt.14, ss.1151560, 2023 (SCI-Expanded, Scopus)

39. The use of pediatric fall risk assessment tool in gastrointestinal endoscopic procedures: A prospective study

Yalcin N., Goktas M. A., gumus e.

Akademik Gastroenteroloji Dergisi , cilt.22, sa.2, ss.103-111, 2023 (TRDizin)

40. Development and validation of a machine learning-based detection system to improve precision screening for medication errors in the neonatal intensive care unit

Yalcin N., Kasikci M., Celik H. T., Allegaert K., Demirkan K., Yigit Ş., et al.

Frontiers in Pharmacology , cilt.14, 2023 (SCI-Expanded, Scopus)

41. Impact of clinical pharmacist-led intervention for drug-related problems in neonatal intensive care unit a randomized controlled trial

Yalçın N., Kaşıkcı M., Çelik H. T., Allegaert K., Demirkan K., Yiğit Ş.

Frontiers in Pharmacology , cilt.14, 2023 (SCI-Expanded, Scopus)

42. Population pharmacokinetics in critically ill neonates and infants undergoing extracorporeal membrane oxygenation: a literature review

YALÇIN N., SÜRMELİOĞLU N., Allegaert K.

BMJ PAEDIATRICS OPEN , cilt.6, sa.1, 2022 (SCI-Expanded, Scopus)

43. An Artificial Intelligence Approach to Support Detection of Neonatal Adverse Drug Reactions Based on Severity and Probability Scores: A New Risk Score as Web-Tool

Yalçın N., Kaşıkcı M., Çelik H. T., Allegaert K., Demirkan K., Yiğit Ş., et al.

CHILDREN (BASEL) , cilt.9, sa.12, ss.1-10, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed

YALÇIN N., Allegaert K.

European Journal of Clinical Pharmacology , cilt.78, sa.10, ss.1697-1701, 2022 (SCI-Expanded, Scopus)

45. Management of drug-related problems including drug-drug interactions caused by nirmatrelvir/ritonavir in paediatric patients with SARS-CoV-2.

Yalcin N., Demirkan K.

Archives of disease in childhood , 2022 (SCI-Expanded, Scopus)

46. Fetal pharmacogenetic screening to improve neonatal pharmacotherapy: From feasibility to personalized practice.

Yalcin N., Allegaert K.

Molecular genetics and metabolism , cilt.137, sa.1-2, ss.210-212, 2022 (SCI-Expanded, Scopus)

47. Liposomal amphotericin B related late-onset hyperphosphatemia in a pediatric patient with acute myeloid leukemia

Çifci S. A., Yalçın N., Aksu T., Demirkan K.

Journal of Oncology Pharmacy Practice , cilt.28, sa.6, ss.1478-1482, 2022 (SCI-Expanded, Scopus)

48. Novel Method for Early Prediction of Clinically Significant Drug–Drug Interactions with a Machine Learning Algorithm Based on Risk Matrix Analysis in the NICU

Yalçın N., Kaşıkcı Çavdar M., Çelik H. T., Allegaert K., Demirkan K., Yiğit Ş., et al.

JOURNAL OF CLINICAL MEDICINE , cilt.11, sa.16, ss.1-13, 2022 (SCI-Expanded, Scopus)

49. Is everyone invited to the discussion table? A bibliometric analysis COVID-19-related mental health literature

Yalcin N., Bayraktar İ., Karabulut E., de Filippis R., Jaguga F., Karaliuniene R., et al.

GLOBAL MENTAL HEALTH , cilt.9, ss.366-374, 2022 (SCI-Expanded, Scopus)

50. The Impact of Pharmacogenetics on Pharmacokinetics and Pharmacodynamics in Neonates and Infants: A Systematic Review

YALÇIN N., Flint R. B., van Schaik R. H., Simons S. H., Allegaert K.

PHARMACOGENOMICS & PERSONALIZED MEDICINE , cilt.15, ss.675-696, 2022 (SCI-Expanded, Scopus)

51. The potential interaction between COVID-19 vaccines and clozapine: A novel approach for clinical trials

Bayraktar İ., Yalçın N., Demirkan K.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE , cilt.75, sa.8, 2021 (SCI-Expanded, Scopus)

52. Potential Drug-Drug Interactions with Psychotropic Drugs in Pediatric Inpatients: A Cross-Sectional Study.

Yalçın N., Özdemir N., Çak Esen H. T., Çengel Kültür S. E., Demirkan K.

International journal of clinical practice , cilt.75, 2021 (SCI-Expanded, Scopus)

53. COVID-19 and remdesivir in pediatric patients: the invisible part of the iceberg.

Yalçın N., Demirkan K.

Pediatric research , cilt.89, ss.1326-1327, 2021 (SCI-Expanded, Scopus)

54. Physicians' knowledge of potential covid-19 drug-drug interactions: An online survey in turkey.

Sürmelioğlu N., Yalçın N., Kuşçu F., Candevir A., İnal A., Kömür S., et al.

Postgraduate medicine , cilt.133, ss.237-241, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process?

Yalçın N., Ak S., Demirkan K.

European journal of hospital pharmacy : science and practice , cilt.28, 2021 (SCI-Expanded, Scopus)

56. Evaluation of the effect of antibiotics used during parenteral nutrition treatment on Candidemia

YALÇIN N., SÜRMELİOĞLU N., Ozkan-Kuscu O., Kelleci-Cakir B., DEMİRKAN S. K., GÜNDÜZ H. M.

REVISTA DA ASSOCIACAO MEDICA BRASILEIRA , cilt.67, sa.10, ss.1448-1453, 2021 (SCI-Expanded, Scopus)

57. COVID-19 & antiepileptic drugs: Should we pay attention?

Fırat O., Yalçın N., Demirkan K.

Seizure , cilt.80, ss.240-241, 2020 (SCI-Expanded, Scopus)

58. Drug-induced nutritional disorders

YALÇIN N., Armut M., KELLECİ ÇAKIR B., DEMİRKAN S. K.

Clinical Science of Nutrition , cilt.1, sa.3, ss.113-122, 2019 (Hakemli Dergi)

59. Compliance in schizophrenia spectrum disorders: the role of clinical pharmacist

Yalçin N., Ak S., Gürel Ş. C., Çeliker A.

INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY , cilt.34, sa.6, ss.298-304, 2019 (SCI-Expanded, Scopus)

60. Time span of a total parenteral nutrition bag: From consultation to the end of administration

KELLECİ ÇAKIR B., SÜRMELİOĞLU N., YALÇIN N., HALİL M. G., DEMİRKAN S. K., ABBASOĞLU O.

Clinical Science of Nutrition , cilt.1, sa.2, ss.82-85, 2019 (Hakemli Dergi)

61. Time span of a total parenteral nutrition bag: From consultation to the end of administration

KELLECİ ÇAKIR B., SÜRMELİOĞLU N., YALÇIN N., HALİL M. G., DEMİRKAN S. K., ABBASOĞLU O.

Clinical Science of Nutrition , cilt.1, sa.2, ss.82-85, 2019 (Hakemli Dergi)

62. Do Antiepileptic Drugs Used During Electroconvulsive Therapy Impact Treatment Process?

Ak S., Yalcin N.

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY , cilt.38, ss.344-348, 2018 (SCI-Expanded, Scopus)

63. Drug Use in Continuous Renal Replacement Therapy and the Comparison of Electronic Drug Information Resources for Dose Adjustments

Surmelioglu N., Koseleci E., Kelleci B., YALÇIN N., Ekincioglu A. B., Demirkan K., et al.

JOURNAL OF MEDICAL AND SURGICAL INTENSIVE CARE MEDICINE , cilt.9, sa.1, ss.7-11, 2018 (ESCI, Scopus, TRDizin)

64. Comparison of electronic information sources regarding dose adjustments in continuous renal replacement therapy

Surmelioglu N., Kelleci B., YALÇIN N., Hawes E., Bayraktar-Ekincioglu A., Demirkan K.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.217-218, 2018 (SCI-Expanded, Scopus)

65. Clinical Pharmacy Practices in Medical Intensive Care Unit in a University Hospital

SÜRMELİOĞLU N., Kelleci B., YALÇIN N., Demirkan K.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACY , cilt.40, sa.1, ss.237, 2018 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 23

1. NUTRITION EDUCATION IN PHARMACY SCHOOLS (NEPS): EXPERIENCE FROM TÜRKIYE

KELLECİ ÇAKIR B., YALÇIN N.

46th European Society for Clinical Nutrition and Metabolism (ESPEN) Congress on Clinical Nutrition & Metabolism, Milan, İtalya, 7 - 10 Eylül 2024, (Özet Bildiri)

2. Model informed precision dosing in paediatric intensive care units: a randomized clinical trial

YALÇIN N.

European Paediatric Translational Research Infrastructure (EPTRI) Scientific Meeting, Bari, İtalya, 18 - 19 Temmuz 2024, (Özet Bildiri)

3. FACTORS AFFECTING FALL HISTORY AND FALL RISK IN GERIATRIC PATIENTS

YALÇIN N., HALİL M. G.

5.Uluslararası ve 16.Akademik Geriatri Kongresi, Ankara, Türkiye, 27 Eylül 2023, (Özet Bildiri)

4. DEXMEDETOMIDINE USE FOR ANALGESIA IN PRETERM BABIES

KAYKI G., YALÇIN N., ÇELİK H. T., YİĞİT Ş.

11th European Paediatric Association's (Europaediatrics) Congress, Antalya, Türkiye, 17 - 21 Nisan 2024, (Özet Bildiri)

5. Erişkin kistik fibrozis hastalarında meropenem ilaç düzeyi izlemi

AKMAN AR E. D., YALÇIN N., KARA E., İNKAYA A. Ç., DAMADOĞLU E., KALYONCU A. F., et al.

Türk Toraks Derneği 27. Kongresi, Girne, Kıbrıs (Kktc), 29 Nisan - 03 Mayıs 2024, (Özet Bildiri)

6. Significant Impact of Total Duration of Clozapine Use on Norclozapine Serum Levels: A Multivariate Retrospective Analysis

BAYRAKTAR İ., OCAK M., YALÇIN N., GÜREL Ş. C., DEMİRKAN S. K.

American College of Clinical Pharmacy Annual Meeting, Dallas-Texas, Amerika Birleşik Devletleri, 11 - 14 Kasım 2023, cilt.6, ss.1501, (Özet Bildiri)

7. Yenidoğan Yoğun Bakım Ünitesinde İki Yıllık Deksmedetomidin Deneyimi

KAYKI G., YALÇIN N., ÇELİK H. T., YİĞİT Ş.

Ankara Pediatri Kongresi, 9 - 11 Kasım 2023, (Özet Bildiri)

8. PSYCHIATRY AND MENTAL HEALTH RESEARCH IN DEVELOPING COUNTRIES. CHALLENGES AND RECOMMENDATIONS

Ramalho R., Gonzalez-Diaz J. M., YALÇIN N.

23rd World Psychiatric Association (WPA) Congress, Vienna, Avusturya, 28 Eylül 2023, (Özet Bildiri)

9. Drug-drug interactions and adverse drug reactions in neonates

YALÇIN N.

ESDPPP Congress, Prag, Çek Cumhuriyeti, 28 - 30 Haziran 2023, (Özet Bildiri)

10. EVALUATION OF ATTITUDES TOWARDS PSYCHOTROPIC MEDICATIONS IN ADOLESCENTS WITH A DEVELOPED NEW SCALE

BAYRAKTAR İ., YALÇIN N., KARABULUT E., NALBANT K., ÇENGEL KÜLTÜR S. E., DEMİRKAN S. K.

50th European Society of Clinical Pharmacy (ESCP) Symposium on Clinical Pharmacy, Polypharmacy and ageing, Prague, Çek Cumhuriyeti, 19 Ekim 2022, cilt.44, ss.1500, (Özet Bildiri)

11. Selected Abstracts for Oral Presentation and Poster Presentation

YALÇIN N., DEMİRKAN S. K., YİĞİT Ş., ÇELİK H. T.

12th KEPAN Congress, Türkiye, 12 - 14 Mart 2021, (Tam Metin Bildiri)

12. IS THERE A PROBLEM IN ACHIEVING THE TARGET IN PARENTERAL NUTRITION TREATMENT OF PEDIATRIC PATIENTS?

YALÇIN N., GÖKTAŞ M. A., KELLECİ ÇAKIR B., EKİNCİOĞLU A., DEMİRKAN S. K., ÖZEN H.

European Society for Clinical Nutrition and Metabolism (ESPEN) 2020 Virtual Congress, 19 - 21 Eylül 2020, cilt.40, ss.575, (Özet Bildiri)

13. Physicians’ Attitudes Towards Medication Related Nutrition Disorders

Yalçın N., Kelleci Çakır B., Ekincioğlu A., Demirkan S. K., Halil M. G., Abbasoğlu O.

41st ESPEN Congress, Krakow, Polonya, 31 Ağustos - 03 Eylül 2019, cilt.38, ss.245, (Özet Bildiri)

14. Psychopharmacology & polypharmacy

Yalçın N.

11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology, Antalya, Türkiye, 18 - 21 Nisan 2019, cilt.29, sa.1, ss.411-412, (Özet Bildiri)